Skip to content

Leadership in AAV Gene Therapy

Our Vision

Bringing life-saving and life-altering cell and gene therapies to all.

Life-saving AAV gene therapy company

Our Fully Equipped Cell and Gene Therapy Facility

Our Greater Boston area site is equipped for

2, 50, and 2000L scales for process development

500L for GMP manufacturing.

Close to Boston and Cambridge, near some of the best educational institutions,

we have a vast array of scientific and business expertise.

Oxford Biomedica’s state-of-the-art,

91,000-sq-ft cell and gene therapy manufacturing facility provides full-scope process and analytical development, and GMP manufacturing.

Our facility is equipped to

support multiple products concurrently

offers single-use technology, eliminating potential for cross-contamination.

Our Plasmid Systems

The inAAVate™ platform of services has the

flexibility and adaptability to support both dual- and triple-plasmid transfection systems

design and optimization to maximize performance and increase product quality

Rigorous analytics have helped optimize both dual- and triple-plasmid system integration, so we can tailor our services to your specific needs.

Our Purification Process

Our proprietary purification process* is extraordinarily adept at separating empty and full capsids. We have demonstrated consistent isolation of full capsids

achieving >90% full AAV vector at commercial scales

*Patent pending.

Together, these aspects of our process allow us to

  • produce your product quickly
  • save time and resources
  • move your product through drug development, IND or CTA, clinic, BLA, and to market faster to benefit patients

The Force for Greater Good

Through novel technology, high-level expertise, and an accelerated learning approach, we aim to generate life-altering treatments for all.

Interested in learning more?

Let’s talk!